Searched for
EMCURE PHARMACEUTICALS LISTING
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...- Shark tank fame Namita Thapar shares an emotional Mirza Ghalib shayari post Emcure IPO's robust listingThe robust listing met expectations, reflecting the company's long-term potential. Analysts recommend that investors maintain their positio...
- Emcure Pharma shares jump over 4% post listing. Should you buy, sell or hold?Pune-based Emcure Pharmaceuticals listed at Rs 1,325, a 31.4% premium on Rs 1,008 IPO price. QIBs subscribed 195.8 times, non-institutional...
- Emcure Pharma shares debut with 31% premium over issue priceBefore listing, the company's shares traded at a Rs 360 premium in the grey market. It raised Rs 582 crore from anchor investors, including...
- Emcure Pharmaceuticals IPO share allotment likely on Monday. Here's how you can check the status.
- Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?Emcure Pharma IPO: Emcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity issuance and OFS. Namita Th...
- Emcure Pharmaceuticals IPO fully subscribed on Day 1. Check GMP and other detailsEmcure Pharmaceuticals' IPO attracts high demand from investors, with a price range of Rs 960-1008 per share. Analysts foresee business imp...
- Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issueEmcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximatel...
- Bain Capital-backed Emcure Pharma to float IPO on July 3Emcure Pharmaceuticals, backed by Bain Capital, is set to launch its IPO on July 3. The IPO includes fresh equity shares issuance and Offer...
- Ola Electric, Emcure Pharma get Sebi nod for IPOs, setting stage for big listingsThe Bengaluru-based company had filed its draft prospectus with Sebi in December last year. The issue comprises a fresh equity sale of Rs 5...
- Emcure Pharma to launch IPO in 3 months: Namita Thapar of Shark Tank fameShark Tank fame and Executive Director of Emcure Pharmaceuticals, Namita Thapar said at the ET NOW Global Business Summit 2024 on February ...
- Bain Capital-backed Emcure Pharma files fresh IPO papers with SebiThose selling shares in the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity m...
- Emcure Pharmaceuticals gets Sebi's go-ahead to float IPOAs part of the OFS, promoters — Satish Mehta will offload 20.30 lakh equity shares, Sunil Mehta will sell 2.5 lakh equity shares — and inve...
- PEs in talks for Emcure stake; promoters eye $2 billion valuationJM Financial is advising the company for the stake sale.
- Pharma stocks soar despite US lawsuitAmong other listed stocks out of the five, Cadila Healthcare gained 2.87 per cent at Rs 512 at around the same time.
- Emcure Pharmaceuticals acquires Canadian company and its marketing arm MarcanMarcan Pharma has over 60 approved products that are mainly available via McKesson and Kohl & Frisch, among other wholesalers, it claimed.
- Blackstone to sell its stake in Emcure Pharma to Bain CapitalPrivate equity major Blackstone is selling its stake in Pune-based Emcure Pharmaceuticals to Bain Capital.
- Blackstone in talks with Bain Capital to sell 13.09% stake in Emcure PharmaThe deal will mark Blackstone's second exit from its Indian portfolio after it had sold its stake in back-office provider Intelenet to the ...
- Emcure Pharmaceuticals files DRHP for IPOEmcure Pharmaceuticals today said it has filed a DRHP with the SEBI for launching an initial public offer to raise an estimated Rs 300 cror...
- Apax, KKR in talks to acquire Blackstone stake in EmcureHealthcare is 1 of the 5 sectors in which Apax Partners invests globally, besides technology & telecom, retail & consumer, media, financial...
Load More
